ResMed houdt beleggersbijeenkomst op 4 april 2019
SAN DIEGO-(BUSINESS WIRE)- ResMed (NYSE: RMD) (ASX: RMD) kondigde vandaag aan dat het een investeerdersvergadering zal organiseren op donderdag 4 april om de recente overnames van het bedrijf, bestaande joint ventures en strategie met betrekking tot respiratoire zorg en out-of-hospital software te bespreken.
De extra informatie betreffende de investeerdersvergadering, met inbegrip van de specifieke tijd en webcastverbinding voor de presentaties, zal ongeveer één week voorafgaande aan de gebeurtenis ter beschikking worden gesteld en kan worden geraadpleegd door http://investor.resmed.com. te bezoeken. De ruimte is beperkt en daarom is deelname aan het evenement persoonsgebonden en alleen op uitnodiging beschikbaar.
ResMed to Host an Investor Meeting on April 4, 2019
SAN DIEGO–(BUSINESS WIRE)– ResMed (NYSE: RMD) (ASX: RMD) today announced it will host an investor meeting on Thursday, April 4th to discuss the Company’s recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software.
Additional information regarding the investor meeting, including the specific time and webcast link for the presentations, will be made available approximately one week prior to the event and may be accessed by visiting http://investor.resmed.com. Space for the event is limited and therefore in-person attendance is available by invitation only.
Presentations at the investor meeting will be transmitted by a live webcast, which may be accessed by visiting http://investor.resmed.com. A replay of the webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible for approximately one year thereafter.
About ResMed
At ResMed (NYSE: RMD) (ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190321005696/en/
Contacts
For media:
Jayme Rubenstein
+1 858.836.6798
news@resmed.com
For investors:
Amy Wakeham
+1 858.836.5000
investorrelations@resmed.com